BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144


SEARCH JOBS




Industry
Pharmaceutical






 Company News
RedHill Biopharma Ltd. (RDHL)'s Investor Webcast Forum Provides Update On The RHB-105 Phase III Program And Potential H. Pylori Eradication Market 5/18/2015 7:33:47 AM
RedHill Biopharma Ltd. (RDHL) To Present At The Biotrinity 2015 Partnering Conference 5/8/2015 8:22:55 AM
RedHill Biopharma Ltd. (RDHL) To Host Investor Webcast Forum Following Completion Of RHB-105 Dosing In Phase III Study 5/7/2015 7:33:33 AM
RedHill Biopharma Ltd. (RDHL) To Present At The Oppenheimer 16th Annual Israeli Conference 5/4/2015 2:57:15 PM
RedHill Biopharma Ltd. (RDHL) Reports Results For The First Quarter Of 2015 4/30/2015 8:40:43 AM
RedHill Biopharma Ltd. (RDHL) To Present At The Bionetwork East 2015 Partnering Conference 4/28/2015 8:00:12 AM
RedHill Biopharma Ltd. (RDHL) Announces Completion Of Patient Enrollment In A Phase III Study Of RHB-105 For H. Pylori Infection 4/27/2015 7:34:58 AM
RedHill Biopharma Ltd. (RDHL) To Host First Quarter 2015 Financial Results Conference Call On April 30, 2015 4/21/2015 10:22:44 AM
RedHill Biopharma Ltd. (RDHL) Receives Notice Of Allowance For Additional U.S. Patent For RHB-105 H. Pylori Bacterial Infection Treatment 4/16/2015 8:57:46 AM
RedHill Biopharma Ltd. (RDHL) Will Snag Small Molecule Rights from Apogee for $5.5M 3/31/2015 9:43:33 AM
12345678910...